GlassScriptPhysician profile
Matthias Ringelmann
NPI 1285327239
$2,177.53
in general payments reported to CMS, 2019-2025
11 companies · $1,501 in 2025
The $1,501 reported for 2025 was more than what 78% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $382 · 2024: $294 · 2025: $1,501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,177.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $551.78 | 2024-2025 | Irrisept |
| Davol INC. | $448.94 | 2023-2025 | Phasix Mesh, Arista Ah Flexitip |
| Teleflex LLC | $277.41 | 2025 | Quikclot, Titan Sgs Bailout Chuck |
| Baxter Healthcare | $212.86 | 2023-2025 | |
| Kerecis Limited | $160.39 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Acera Surgical, INC. | $140.38 | 2025 | Restrata Wound Matrix |
| Medtronic, INC. | $105.48 | 2025 | Transorb |
| Conmed Corporation | $104.58 | 2025 | Airseal |
| Solventum Corporation | $92.31 | 2025 | Prevena, V.A.C.Instill, V.A.C.Ulta |
| Cook Biotech Incorporated | $72.22 | 2023 | Biodesign |
| Intuitive Surgical, INC. | $11.18 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthias Ringelmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.